4//SEC Filing
SEELEY BRUCE J. 4
Accession 0000899243-21-011366
CIK 0000891293other
Filed
Mar 11, 7:00 PM ET
Accepted
Mar 12, 6:45 PM ET
Size
7.4 KB
Accession
0000899243-21-011366
Insider Transaction Report
Form 4
SEELEY BRUCE J.
EVP, Chief Commercial Officer
Transactions
- Award
Common Stock
2020-07-01$0.98/sh+5,000$4,900→ 37,500 total - Award
Stock Option (right to buy)
2021-03-10+200,000→ 200,000 totalExercise: $3.30Exp: 2031-03-10→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]Shares acquired under the CTI BioPharma Corp. 2007 Employee Stock Purchase Plan.
- [F2]The stock option will vest in six equal semi-annual installments over a three-year period, subject to continued employment with the Company through the applicable vesting dates. The stock option is also subject to stockholder approval of an increase in the share reserve under the Company's 2017 Equity Incentive Plan, which approval must occur within one year from the grant date
Documents
Issuer
CTI BIOPHARMA CORP
CIK 0000891293
Entity typeother
Related Parties
1- filerCIK 0001474462
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 7:00 PM ET
- Accepted
- Mar 12, 6:45 PM ET
- Size
- 7.4 KB